Steve Saviuk, president and CEO of Valeo Pharma (VPH.C), talks about the transformative partnerships with international players such as Novartis and members of the Canadian Healthcare Industry, that allow the company to bring leading innovative products to the Canadian market. Tune in!
Valeo Pharma (VPH.C) CEO Steve Saviuk talks specialty pharma opportunity (Ep4) Chris’ Corner
Latest Articles
- Prismo Metals (PRIZ.C): Four bets on the table, in gold, silver, and copper
- East Africa Metals Inc.: Navigating Challenges in Gold Exploration
- AbraSilver Resource Corp.: Navigating Silver and Gold Markets in Argentina
- Beyond Lithium Inc.: Navigating the Shifting Lithium Market
- Argo Living Soils Corp.: Navigating Sustainable Growth Amidst Financial Challenges
Top Searches
Abitibi Greenstone Belt Barrick Gold best canadian cannabis company biotech Bitcoin blockchain bullion Canada cannabis CBD China Chris Parry covid cryptocurrency DEFN.V Fraser Institute gambling Gold gold price. gold prices Greg Nolan hemp inflation interest rates investing investments lithium Lukas Kane marijuana mining money Newmont Goldcorp Nexus Gold pharmaceuticals psychedelics resources silver stock market stocks technology trading uranium wealth wealth creation weed
Leave a Reply